PURE BIOSCIENCE, INC. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pure Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q2 2024.
  • Pure Bioscience, Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was -$699K, a 31.7% increase year-over-year.
  • Pure Bioscience, Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$3.19M, a 19.1% increase year-over-year.
  • Pure Bioscience, Inc. annual Operating Income (Loss) for 2024 was -$3.19M, a 19.1% increase from 2023.
  • Pure Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$3.94M, a 5.88% decline from 2022.
  • Pure Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$3.72M, a 61.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$3.19M -$699K +$325K +31.7% May 1, 2024 Jul 31, 2024 10-K 2024-10-29
Q1 2024 -$3.52M -$817K +$58K +6.63% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 -$3.57M -$964K +$94K +8.89% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 -$3.67M -$711K +$275K +27.9% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-14
Q2 2023 -$3.94M -$1.02M +$206K +16.7% May 1, 2023 Jul 31, 2023 10-K 2024-10-29
Q1 2023 -$4.15M -$875K -$116K -15.3% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 -$4.03M -$1.06M -$118K -12.6% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 -$3.92M -$986K -$191K -24% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-14
Q2 2022 -$3.72M -$1.23M -$502K -69% May 1, 2022 Jul 31, 2022 10-K 2023-10-30
Q1 2022 -$3.22M -$759K +$51K +6.3% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 -$3.27M -$940K -$346K -58.2% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 -$2.93M -$795K -$616K -344% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
Q2 2021 -$2.31M -$728K -$2.05M -155% May 1, 2021 Jul 31, 2021 10-K 2022-10-28
Q1 2021 -$260K -$810K -$1.28M -271% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $1.02M -$594K +$69K +10.4% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 $955K -$179K +$951K +84.2% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q2 2020 $4K $1.32M +$2.15M May 1, 2020 Jul 31, 2020 10-K 2021-10-28
Q1 2020 -$2.14M $474K +$1.39M Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-15
Q4 2019 -$3.53M -$663K +$629K +48.7% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-15
Q3 2019 -$4.16M -$1.13M +$1.43M +55.9% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-15
Q2 2019 -$5.59M -$822K +$554K +40.3% May 1, 2019 Jul 31, 2019 10-K 2020-10-08
Q1 2019 -$6.14M -$912K +$799K +46.7% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-11
Q4 2018 -$6.94M -$1.29M +$736K +36.3% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-12
Q3 2018 -$7.68M -$2.56M -$636K -33% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-13
Q2 2018 -$7.04M -$1.38M +$38K +2.69% May 1, 2018 Jul 31, 2018 10-K 2019-10-30
Q1 2018 -$7.08M -$1.71M -$118K -7.41% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-13
Q4 2017 -$6.96M -$2.03M -$624K -44.4% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-06
Q3 2017 -$6.34M -$1.93M -$330K -20.7% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-13
Q2 2017 -$6.01M -$1.41M +$33K +2.28% May 1, 2017 Jul 31, 2017 10-K 2018-10-25
Q1 2017 -$6.04M -$1.59M -$104K -6.99% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-13
Q4 2016 -$5.94M -$1.4M +$855K +37.8% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-14
Q3 2016 -$6.79M -$1.6M +$265K +14.2% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-14
Q2 2016 -$7.06M -$1.45M +$427K +22.8% May 1, 2016 Jul 31, 2016 10-K 2017-10-26
Q1 2016 -$7.48M -$1.49M +$611K +29.1% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-08
Q4 2015 -$8.1M -$2.26M -$523K -30.1% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-02
Q3 2015 -$7.57M -$1.86M +$68K +3.52% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-14
Q2 2015 -$7.64M -$1.87M +$791K +29.7% May 1, 2015 Jul 31, 2015 10-K 2016-10-27
Q1 2015 -$8.43M -$2.1M +$84K +3.85% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-09
Q4 2014 -$8.52M -$1.74M +$1.49M +46.1% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-09
Q3 2014 -$10M -$1.93M +$1.9M +49.6% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-10
Q2 2014 -$11.9M -$2.67M -$505K -23.4% May 1, 2014 Jul 31, 2014 10-K 2015-10-28
Q1 2014 -$11.4M -$2.18M -$607K -38.5% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-11
Q4 2013 -$10.8M -$3.22M -$1.41M -78% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-04
Q3 2013 -$9.38M -$3.83M -$2.04M -114% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-11
Q2 2013 -$7.34M -$2.16M +$213K +8.98% May 1, 2013 Jul 31, 2013 10-K 2014-10-28
Q1 2013 -$7.55M -$1.58M +$249K +13.6% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-10
Q4 2012 -$7.8M -$1.81M +$383K +17.5% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-13
Q3 2012 -$8.18M -$1.79M +$570K +24.1% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-12
Q2 2012 -$8.75M -$2.37M -$345K -17% May 1, 2012 Jul 31, 2012 10-K 2013-10-24
Q1 2012 -$8.41M -$1.83M -$7K -0.39% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 -$8.4M -$2.19M +$303K +12.1% Nov 1, 2011 Jan 31, 2012 10-Q 2013-02-25
Q3 2011 -$8.71M -$2.36M -$338K -16.7% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-11
Q2 2011 -$8.37M -$2.03M May 1, 2011 Jul 31, 2011 10-K 2012-10-29
Q1 2011 -$1.82M Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-13
Q4 2010 -$2.5M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q3 2010 -$2.02M Aug 1, 2010 Oct 31, 2010 10-Q/A 2011-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.